
Monica M. Bertagnolli, M.D., is a surgical oncologist and cancer researcher currently serving as a Senior Fellow in Healthcare Policy at the Harvard Kennedy School. From November 2023- January 2025 she was the 17th director of the National Institutes of Health. Prior to this, she was the director of the National Cancer Institute (NCI), Richard E. Wilson Professor of Surgery at Harvard Medical School, and Chief of Surgical Oncology at Brigham and Women's Hospital and Dana-Farber Cancer Institute. Throughout her career, Dr. Bertagnolli has been at the forefront of the field of translational oncology. Over the past decade, she has championed collaborative initiatives to enable a learning healthcare system by transforming the data infrastructure for clinical research. She is a past president of the American Society of Clinical Oncology and served on the board of directors of the American Cancer Society and the Prevent Cancer Foundation. Dr. Bertagnolli was elected to the National Academy of Medicine in 2021. She graduated from Princeton University with a Bachelor of Science in Engineering degree and attended medical school at the University of Utah. She trained in surgery at Brigham and Women's Hospital and was a research fellow in tumor immunology at the Dana-Farber Cancer Institute.
Professor
Medical School
1981 – 1985
Residency
1985 – 1991
Fellowship
1991 – 1993